Imagin Medical Inc.
IME
CNSX
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 218.00K | 225.70K | 229.60K | 113.90K | 346.10K |
| Depreciation & Amortization | 34.50K | 34.30K | 34.10K | 18.50K | 6.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 252.50K | 260.40K | 484.00K | 818.90K | 653.00K |
| Operating Income | -252.50K | -260.40K | -484.00K | -818.90K | -653.00K |
| Income Before Tax | 1.64M | -645.60K | 11.80K | -3.58M | 3.64M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 1.64M | -645.60K | 11.80K | -3.58M | 3.64M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.64M | -645.60K | 11.80K | -3.58M | 3.64M |
| EBIT | -252.50K | -260.40K | -484.00K | -818.90K | -653.00K |
| EBITDA | -218.00K | -226.10K | -449.90K | -800.30K | -647.00K |
| EPS Basic | 0.15 | -0.06 | 0.00 | -0.34 | 0.36 |
| Normalized Basic EPS | 0.09 | -0.04 | 0.00 | 0.00 | 0.23 |
| EPS Diluted | 0.15 | -0.06 | 0.00 | -0.34 | 0.36 |
| Normalized Diluted EPS | 0.09 | -0.04 | 0.00 | 0.00 | 0.23 |
| Average Basic Shares Outstanding | 10.83M | 10.83M | 10.83M | 10.38M | 10.00M |
| Average Diluted Shares Outstanding | 10.83M | 10.83M | 10.83M | 10.38M | 10.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
